Tag Archives: Quantum Genomics

Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF)

New York, NY, August 10, 2019 – Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. It is estimated that there are around 150 million people worldwide that are affected by treatment- resistant hypertension, […]

Comments Off on Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF) Continue Reading →